387 related articles for article (PubMed ID: 22281187)
21. A new modification of anti-tubercular active molecules.
Imramovský A; Polanc S; Vinsová J; Kocevar M; Jampílek J; Recková Z; Kaustová J
Bioorg Med Chem; 2007 Apr; 15(7):2551-9. PubMed ID: 17306980
[TBL] [Abstract][Full Text] [Related]
22. A duplicated nitrotienyl derivative with antimycobacterial activity: synthesis, X-ray crystallography, biological and mutagenic activity tests.
Rando DG; Doriguetto AC; Tomich de Paula da Silva CH; Ellena J; Sato DN; Leite CQ; Varanda EA; Ferreira EI
Eur J Med Chem; 2006 Oct; 41(10):1196-200. PubMed ID: 16828526
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, antimycobacterial activity and in vitro cytotoxicity of 5-chloro-N-phenylpyrazine-2-carboxamides.
Zitko J; Servusová B; Paterová P; Mandíková J; Kubíček V; Kučera R; Hrabcová V; Kuneš J; Soukup O; Doležal M
Molecules; 2013 Dec; 18(12):14807-25. PubMed ID: 24317522
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.
Sirisha K; Bikshapathi D; Achaiah G; Reddy VM
Eur J Med Chem; 2011 May; 46(5):1564-71. PubMed ID: 21382653
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and Antimicrobial Evaluation of 6-Alkylamino-N-phenylpyrazine-2-carboxamides.
Servusova-Vanaskova B; Paterova P; Garaj V; Mandikova J; Kunes J; Naesens L; Jílek P; Dolezal M; Zitko J
Chem Biol Drug Des; 2015 Oct; 86(4):674-81. PubMed ID: 25676890
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues.
Kozic J; Novotná E; Volková M; Stolaříková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2012 Oct; 56():387-95. PubMed ID: 22907036
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives.
Seitz LE; Suling WJ; Reynolds RC
J Med Chem; 2002 Dec; 45(25):5604-6. PubMed ID: 12459027
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and biological activity of pyrazinamide derivatives for anti-Mycobacterium tuberculosis.
Zhou S; Yang S; Huang G
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1183-1186. PubMed ID: 28870094
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles.
Kazimierczuk Z; Andrzejewska M; Kaustova J; Klimesova V
Eur J Med Chem; 2005 Feb; 40(2):203-8. PubMed ID: 15694655
[TBL] [Abstract][Full Text] [Related]
30. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
Indumathi S; Perumal S; Banerjee D; Yogeeswari P; Sriram D
Eur J Med Chem; 2009 Dec; 44(12):4978-84. PubMed ID: 19781824
[TBL] [Abstract][Full Text] [Related]
31. New potentially active pyrazinamide derivatives synthesized under microwave conditions.
Jandourek O; Dolezal M; Kunes J; Kubicek V; Paterova P; Pesko M; Buchta V; Kralova K; Zitko J
Molecules; 2014 Jul; 19(7):9318-38. PubMed ID: 24995919
[TBL] [Abstract][Full Text] [Related]
32. A note on the antitubercular activities of 1-aryl-5-benzylsulfanyltetrazoles.
Adamec J; Waisser K; Kunes J; Kaustová J
Arch Pharm (Weinheim); 2005 Aug; 338(8):385-9. PubMed ID: 16041837
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antimycobacterial activity of some phthalimide derivatives.
Akgün H; Karamelekoğlu I; Berk B; Kurnaz I; Sarıbıyık G; Oktem S; Kocagöz T
Bioorg Med Chem; 2012 Jul; 20(13):4149-54. PubMed ID: 22633120
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of in vitro anti-tuberculosis activity of N-substituted glycolamides.
Daryaee F; Kobarfard F; Khalaj A; Farnia P
Eur J Med Chem; 2009 Jan; 44(1):289-95. PubMed ID: 18436347
[TBL] [Abstract][Full Text] [Related]
35. New fluorine-containing hydrazones active against MDR-tuberculosis.
Vavříková E; Polanc S; Kočevar M; Horváti K; Bosze S; Stolaříková J; Vávrová K; Vinšová J
Eur J Med Chem; 2011 Oct; 46(10):4937-45. PubMed ID: 21855181
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines.
Chhabria MT; Jani MH
Eur J Med Chem; 2009 Oct; 44(10):3837-44. PubMed ID: 19423196
[TBL] [Abstract][Full Text] [Related]
37. QSAR modeling of a set of pyrazinoate esters as antituberculosis prodrugs.
Fernandes JP; Pasqualoto KF; Felli VM; Ferreira EI; Brandt CA
Arch Pharm (Weinheim); 2010 Feb; 343(2):91-7. PubMed ID: 20099263
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of Leubethanol derivatives and evaluation against Mycobacterium tuberculosis.
Perez-Meseguer J; Del Olmo E; Alanis-Garza B; Escarcena R; Garza-González E; Salazar-Aranda R; Feliciano AS; de Torres NW
Bioorg Med Chem; 2012 Jul; 20(13):4155-63. PubMed ID: 22626551
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of novel substituted pyrazolyl-2-toluidinomethanethione and pyrazolyl-2-methoxyanilinomethanethione as potential antitubercular agents.
Ali MA; Yar MS
Acta Pol Pharm; 2007; 64(2):139-46. PubMed ID: 17665863
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
